Related Experiment Videos
Selection of carriers for alkylating moieties to increase their antitumor specificity: a different aspect
Cancer Treatment Reports
|August 1, 1977
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
NCI-EORTC-AACR--11th Symposium on New Drugs in Cancer Therapy: Gene therapy and new drugs. 7-10 November 2000, Amsterdam, The Netherlands.
IDrugs : the investigational drugs journal·2005
Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer.
Current opinion in molecular therapeutics·2001
Thymitaq (Zarix).
Current opinion in investigational drugs (London, England : 2000)·2001
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987